If you suffered losses in Inspire Medical Systems stock, contact Inspire Medical Systems stock loss lawyer Timothy L. Miles today
INTRODUCTION TO THE INSPIRE MEDICAL SYSTEMS CLASS ACTION LAWSUIT Contact us about an Inspire Medical Systems class action lawsuit if you suffered losses in Inspire Medical Systems stock
The Inspire Medical Systems class action lawsuit seeks to represent purchasers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”). Captioned City of Hollywood Firefighters’ Pension Fund v. Inspire Medical Systems, Inc., No. 23-cv-03884 (D. Minn.), the Inspire Medical Systems class action lawsuit charges Inspire Medical Systems and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered losses in Inspire Medical Systems stock and wish to serve as lead plaintiff in the Inspire Medical Systems class action lawsuit, or just have general questions about your rights as a shareholder, please contact Inspire Medical Systems Stock Loss Lawyer Timothy L. Miles at no charge by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the Inspire Medical Systems class action lawsuit must be filed with the court no later than February 20, 2024. Read on for answers to six frequently asked questions by investors about the Inspire Medical Systems class action lawsuit. what are the ALLEGATIONS IN THE INSPIRE MEDICAL SYSTEMS CLASS ACTION LAWSUIT?
Inspire Medical Systems offers the only obstructive sleep apnea (“OSA”) device that has been approved by the Food and Drug Administration (“FDA”) for treatment of the root cause of sleep apnea by working inside the body with the patient’s natural breathing process. Inspire Medical Systems calls the treatment “Inspire therapy.” For patients to receive insurance coverage for Inspire therapy, they are required to visit a doctor to secure prior authorization. Inspire Medical Systems maintains an Advisor Care Program team to assist with this process, including the scheduling of appointments, which was historically handled through telephone calls with physician offices. In 2022, Inspire Medical Systems introduced a pilot program (the “Acceleration Program”), through which Inspire Medical Systems’ Advisor Care Program team with the customer on the phone would directly access doctors’ electronic schedules and schedule doctor appointments online, without the need for phone calls.
The Inspire Medical Systems class action lawsuit alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose problems with the Acceleration Program, including a decrease in the number of prior authorization submissions for Inspire therapy. The Inspire Medical Systems class action lawsuit alleges that investors learned the truth on November 7, 2023 when Inspire Medical Systems announced disappointing earnings results for the third quarter of 2023, its first reported revenue miss since becoming a public company in 2018. Specifically, the Inspire Medical Systems class action lawsuit further alleges that the company revealed that it had started to “track” problems with the Acceleration Program in the second quarter of 2023, including a decrease in the number of prior authorization submissions for Inspire therapy, and “recogniz[ed] this trend early in the third quarter,” i.e., as early as July 1, 2023. On this news, the price of Inspire Medical Systems’ stock fell by nearly 20%, according to the complaint. WHAT ARE MY CHOICES IF I RECEIVE A NOTICE IN THE INSPIRE MEDICAL SYSTEMS CLASS ACTION LAWSUIT?
First, read the notice very carefully. You have two choices. First, you can do nothing and remain a member of the class represented by lead counsel. Second, if you believe you have a large enough loss to justify it, you can opt out of the Inspire Medical Systems class action lawsuit and file your own separate lawsuit. Note, that if you opt out, you will not be able to participate in any settlement or recovery obtained in the Inspire Medical Systems class action lawsuit.
WHAT IS A SECURTIES FRAUD CLASS ACTION SUCH AS THE INSPIRE MEDICAL SYSTEMS CLASS ACTION LAWSUIT?
A securities fraud class action refers to a legal action taken by a group of investors who have suffered financial losses as a result of fraudulent activities committed by a company or its executives. This type of lawsuit is typically filed when a company misrepresents or withholds important information from investors, leading to a decline in the value of their investments. The purpose of a securities fraud class action is to seek compensation for the affected investors and hold the company accountable for its fraudulent practices. Securities fraud class actions are governed by the Private Securities Litigation Reform Act (PSLRA).
One notable securities fraud class action lawsuit is the Inspire Medical Systems class action lawsuit lawsuit. In this case, investors who purchased Inspire Medical Systems securities alleged that the company made false and misleading statements and misled investors, and when the truth was ultimately disclosed, they suffered losses from purchasing shares that had been artificially inflated by the false and misleading information. Securities fraud class actions are typically initiated by a lead plaintiff or a group of lead plaintiffs who represent the interests of all the affected investors. The lead plaintiff is often an institutional investor or a large shareholder who has suffered substantial losses and possesses the resources and expertise to effectively pursue the lawsuit on behalf of the class. The lead plaintiff's role is crucial in coordinating with legal counsel, gathering evidence, and making strategic decisions throughout the litigation process. To proceed with a securities fraud class action, the lead plaintiff must demonstrate that there is a common issue of law or fact among the members of the class and that a class action is the most efficient and appropriate method for resolving their claims. If these requirements are met, the court will certify the lawsuit as a class action, allowing all eligible investors to participate in the litigation and share in any potential recovery. Once certified, the securities fraud class action typically goes through several stages, including discovery, where both parties exchange relevant documents and information, and motion practice, where each side presents legal arguments to the court. If the case does not settle during these stages, it may proceed to trial, where a jury or judge will determine liability and damages. In securities fraud class actions, the defendants are usually the company accused of fraud and its executives who were involved in the fraudulent activities. The lead plaintiff seeks damages on behalf of all class members, which may include compensation for their financial losses, interest, attorneys' fees, and other costs incurred throughout the litigation process. In conclusion, a securities fraud class action is a legal mechanism used by investors to seek compensation for financial losses resulting from fraudulent activities committed by a company. The Inspire Medical Systems class action lawsuit serves as an example of how investors can hold companies accountable for their alleged misrepresentations and omissions. These lawsuits play an essential role in protecting investor rights and promoting transparency in the financial markets. WHAT DO THE PLAINTIFFS HAVE TO PROVE TO PREVAIL IN THE INSPIRE MEDICAL SYSTEMS CLASS ACTION LAWSUIT?
To understand the basis of the Inspire Medical Systems class action lawsuit, it is essential to grasp the key elements of securities fraud actions. The majority of securities fraud claims are brought under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. To prevail in a Rule 10b-5 action, a plaintiff must establish six elements:
CAN A NON-U.S. INVESTOR SERVE AS LEAD PLAINTIFF IN THE INSPIRE MEDICAL SYSTEMS LAWSUIT IF THEY SUFFERED LOSSES IN INSPIRE MEDICAL SYSTEMS STOCK?
Yes, courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors. Thus, if a non-U.S. investor suffered losses in Inspire Medical Systems, they may move the Court to be appointed lead plaintiff in the Inspire Medical Systems lawsuit.
IF I SUFFERED LOSSES IN SUFFERED LOSSES IN INSPIRE MEDICAL SYSTEMS STOCK, WHEN CAN I EXPECT TO RECEIVE MY PAYMENT IF THE INSPIRE MEDICAL SYSTEMS CLASS ACTION LAWSUIT SETTLES?
If there is a settlement in the Inspire Medical Systems class action lawsuit, you should receive a court-ordered Notice through the mail which will provide a date when the court will hold a final hearing to decide if it will approve the settlement in the Inspire Medical Systems lawsuit. If your address changed, you may also find lawsuits through sites such as Consumer Action and ClassAction.org along with instructions on how to submit a claim. The Notice will instruct you what you need to do to file a claim. In some class action settlements, you are automatically submitted and need to do nothing further. However, in others, you may be required to submit more information to proceed such as documentation proving your purchase, such as a receipt or brokerage slip or other evidence that you bought or sold Inspire Medical Systems stock during the class period and suffered losses in Inspire Medical Systems stock.
The court will hold a final hearing in the Inspire Medical Systems class action lawsuit on a date provided in the Notice to decide whether to finally approve the settlement. If the Court finally approves the settlement, and there are no objections or appeals, settlement payments will be mailed to all Participating Class Members within a few months. However, if there are objections or appeals, resolving them can take a significant amount of time, perhaps more than a year to resolve the Inspire Medical Systems lawsuit. CONTACT AN INSPIRE MEDICAL SYSTEMS STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN INSPIRE MEDICAL SYSTEMS STOCK ABOUT AN INSPIRE MEDICAL SYSTEMS CLASS ACTION LAWSUIT
If you suffered losses in Inspire Medical Systems stock, contact Inspire Medical Systems stock loss lawyer Timothy L. Miles today for a free case evaluation about an Inspire Medical Systems class action lawsuit. Call today and see what an Inspire Medical Systems stock loss lawyer could do for you if you suffered losses in Inspire Medical Systems stock. The call is free and so is the fee unless we will or settle your case.
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846–6529 Email: [email protected]
Inspire Medical Systems stock loss lawyer Timothy L. MilesNashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2024
Categories
All
|
|
CONTACT
The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: [email protected] HOURS OF OPERATION Mon-Fri: 24/7 Sat-Sun: 24/7 |
RSS Feed